Advancements In Anti-Viral Strategies Against Nipah Virus
DOI:
https://doi.org/10.58222/juvokes.v3i2.1187Kata Kunci:
Nipah, Monoclonal Antibodies, Defective Interfering Particles, One Health, VaccineAbstrak
Since its discovery in Malaysia during the epidemic of 1998, Nipah virus or NiV, member of paramyxoviridae family, has become one of the emerging potential threats to world health due to its uncontrolled rate of fatality and absence of specific therapies. The recent outbreaks in South and Southeast Asia have called for urgent international efforts to curb the virus. Since most infections with NiV bring about severe respiratory and neurological symptoms, treatment has relied on supportive care. There are no human vaccines available for distribution, though some preclinical trials and very limited human trial versions of vaccines are in development. This review article emphasizes on the recent advances in the therapeutic approaches and prevention measures of NiV. New treatment strategies like Defective Interfering Particles and RNA silencing, other than conventional treatments like antiviral drugs have also been discussed.
Referensi
Alam, Ali M. 2022. “Nipah Virus, an Emerging Zoonotic Disease Causing Fatal Encephalitis.” Clinical Medicine, Journal of the Royal College of Physicians of London 22(4).
Debroy, Bishal, Arkajit De, Somdatta Bhattacharya, and Kuntal Pal. 2023. “In Silico Screening of Herbal Phytochemicals to Develop a Rasayana for Immunity against Nipah Virus.” Journal of Ayurveda and Integrative Medicine 14(6). doi: 10.1016/j.jaim.2023.100825.
Foster, Stephanie L., Courtney Woolsey, Viktoriya Borisevich, Krystle N. Agans, Abhishek N. Prasad, Daniel J. Deer, Joan B. Geisbert, Natalie S. Dobias, Karla A. Fenton, Robert W. Cross, and Thomas W. Geisbert. 2022. “A Recombinant VSV-Vectored Vaccine Rapidly Protects Nonhuman Primates against Lethal Nipah Virus Disease.” Proceedings of the National Academy of Sciences of the United States of America 119(12). doi: 10.1073/pnas.2200065119.
Gupta, Amit Kumar, Archit Kumar, Akanksha Rajput, Karambir Kaur, Showkat Ahmed Dar, Anamika Thakur, Kirti Megha, and Manoj Kumar. 2020. “NipahVR: A Resource of Multi-Targeted Putative Therapeutics and Epitopes for the Nipah Virus.” Database 2020. doi: 10.1093/database/baz159.
Johnson, Kendra, Michelle Vu, and Alexander N. Freiberg. 2021. “Recent Advances in Combating Nipah Virus.” Faculty Reviews 10. doi: 10.12703/r/10-74.
Lipin, Raju, Anantha Krishnan Dhanabalan, Krishnasamy Gunasekaran, and Rajadurai Vijay Solomon. 2021. “Piperazine-Substituted Derivatives of Favipiravir for Nipah Virus Inhibition: What Do in Silico Studies Unravel?” SN Applied Sciences 3(1). doi: 10.1007/s42452-020-04051-9.
Loomis, Rebecca J., Guillaume B. E. Stewart-Jones, Yaroslav Tsybovsky, Ria T. Caringal, Kaitlyn M. Morabito, Jason S. McLellan, Amy L. Chamberlain, Sean T. Nugent, Geoffrey B. Hutchinson, Lisa A. Kueltzo, John R. Mascola, and Barney S. Graham. 2020. “Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development.” Frontiers in Immunology 11. doi: 10.3389/fimmu.2020.00842.
Lu, Mingqing, Yanfeng Yao, Hang Liu, Xuekai Zhang, Xuejie Li, Yuanhua Liu, Yun Peng, Tong Chen, Yun Sun, Ge Gao, Miaoyu Chen, Jiaxuan Zhao, Xiao Yu Zhang, Chunhong Yin, Weiwei Guo, Peipei Yang, Xue Hu, Juhong Rao, Entao Li, Gary Wong, Zhiming Yuan, Sandra Chiu, Chao Shan, and Jiaming Lan. 2023. “Vaccines Based on the Fusion Protein Consensus Sequence Protect Syrian Hamsters from Nipah Virus Infection.” JCI Insight 8(23). doi: 10.1172/jci.insight.175461.
Mire, Chad E., Yee Peng Chan, Viktoriya Borisevich, Robert W. Cross, Lianying Yan, Krystle N. Agans, Ha V. Dang, David Veesler, Karla A. Fenton, Thomas W. Geisbert, and Christopher C. Broder. 2020. “A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection.” Journal of Infectious Diseases 221. doi: 10.1093/infdis/jiz515.
Monath, Thomas P., Richard Nichols, Friederike Feldmann, Amanda Griffin, Elaine Haddock, Julie Callison, Kimberly Meade-White, Atsushi Okumura, Jamie Lovaglio, Patrick W. Hanley, Chad S. Clancy, Carl Shaia, Wasima Rida, and Joan Fusco. 2023. “Immunological Correlates of Protection Afforded by PHV02 Live, Attenuated Recombinant Vesicular Stomatitis Virus Vector Vaccine against Nipah Virus Disease.” Frontiers in Immunology 14. doi: 10.3389/fimmu.2023.1216225.
Pillai, Vinod Soman, Gayathri Krishna, and Mohanan Valiya Veettil. 2020. “Nipah Virus: Past Outbreaks and Future Containment.” Viruses 12(4).
Singhai, Monil, Ruchi Jain, Sarika Jain, Manju Bala, Sujeet Singh, and Rajeev Goyal. 2021. “Nipah Virus Disease: Recent Perspective and One Health Approach.” Annals of Global Health 87(1). doi: 10.5334/aogh.3431.
Soltan, Mohamed A., Muhammad Alaa Eldeen, Nada Elbassiouny, Ibrahim Mohamed, Dalia A. El-Damasy, Eman Fayad, Ola A. Abu Ali, Nermin Raafat, Refaat A. Eid, and Ahmed A. Al-Karmalawy. 2021. “Proteome Based Approach Defines Candidates for Designing a Multitope Vaccine against the Nipah Virus.” International Journal of Molecular Sciences 22(17). doi: 10.3390/ijms22179330.
Talukdar, Pratik, Debankita Dutta, Elija Ghosh, Indrani Bose, and Sourish Bhattacharjee. 2023. “Molecular Pathogenesis of Nipah Virus.” Applied Biochemistry and Biotechnology 195(4).
Urmi, Taslima Jamal, Syed Masudur Rahman Dewan, Jannatul Mabia Rahman, Syeda Nusrat Sharmin, and Md Mahadi Hassan. 2023. “Development of Preventive Measures and Treatment Strategies Against Nipah Virus Is a Timely Need: Bangladeshi Perspective.” Clinical Pathology 16.
Welch, Stephen R., Jessica R. Spengler, Sarah C. Genzer, Jo Ann D. Coleman-McCray, Jessica R. Harmon, Teresa E. Sorvillo, Florine E. M. Scholte, Sergio E. Rodriguez, T. Justin O’Neal, Jana M. Ritter, Georgia Ficarra, Katherine A. Davies, Markus H. Kainulainen, Elif Karaaslan, Éric Bergeron, Cynthia S. Goldsmith, Michael K. Lo, Stuart T. Nichol, Joel M. Montgomery, and Christina F. Spiropoulou. 2023. “Single-Dose Mucosal Replicon-Particle Vaccine Protects against Lethal Nipah Virus Infection up to 3 Days after Vaccination.” Science Advances 9(31). doi: 10.1126/sciadv.adh4057.
_1.png)
